Dr. Daruka Mahadevan, MD, PhD
Claim this profileMays Cancer Center
Studies Solid Tumors
Studies Lung Cancer
10 reported clinical trials
12 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
MSI-low positive
2Lung Cancer
Stage IV
MSI-low positive
MSS positive
Affiliated Hospitals
Clinical Trials Daruka Mahadevan, MD, PhD is currently running
LNCB74
for Cancer
This is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and / or recommended phase 2 dose of LNCB74 in participants with advanced solid tumors.
Recruiting1 award Phase 15 criteria
PT217
for Small Cell Lung Cancer
This trial is testing a new antibody treatment called PT217 for patients with certain neuroendocrine cancers who haven't responded to usual treatments. PT217 helps the immune system target and destroy cancer cells by attaching to specific proteins on them.
Recruiting1 award Phase 1 & 2
More about Daruka Mahadevan, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daruka Mahadevan, MD, PhD has experience with
- Pembrolizumab
- SM08502
- PRJ1-3024
- DT2216
- Docetaxel
- Abiraterone
Breakdown of trials Daruka Mahadevan, MD, PhD has run
Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daruka Mahadevan, MD, PhD specialize in?
Daruka Mahadevan, MD, PhD focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Daruka Mahadevan, MD, PhD currently recruiting for clinical trials?
Yes, Daruka Mahadevan, MD, PhD is currently recruiting for 2 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Daruka Mahadevan, MD, PhD has studied deeply?
Yes, Daruka Mahadevan, MD, PhD has studied treatments such as Pembrolizumab, SM08502, PRJ1-3024.
What is the best way to schedule an appointment with Daruka Mahadevan, MD, PhD?
Apply for one of the trials that Daruka Mahadevan, MD, PhD is conducting.
What is the office address of Daruka Mahadevan, MD, PhD?
The office of Daruka Mahadevan, MD, PhD is located at: Mays Cancer Center, San Antonio, Texas 78229 United States. This is the address for their practice at the Mays Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.